Patients who have undergone drug therapy, coronary stenting, or coronary artery bypass surgery for coronary artery disease
Conditions
Interventions
Wearable device worn + online instruction for 3 months
Wearable device worn for 3 months
Sponsors
Department of Cardiovascular Biology and Medicine, Juntendo University School of Medicine, Tokyo, Japan
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: (1) Patients indicated for outpatient cardiac rehabilitation in secondary prevention of coronary artery disease (2) Patients who are 20 years of age or older at the time of obtaining consent. (3) Patients who have been fully informed about their participation in this study, and who have given written consent of their own free will based on a thorough understanding of the study.
Exclusion criteria
Exclusion criteria: (1) Users of implantable medical devices such as cardiac pacemakers and defibrillators (2) Patients diagnosed with acute myocardial infarction, unstable angina pectoris not stabilized by medical treatment, uncontrolled arrhythmia causing subjective symptoms or hemodynamic abnormalities, uncontrolled heart failure, symptomatic severe aortic stenosis, or psychiatric disorder that prevents communication (3) Patients who are judged to be inappropriate for this study by the principal investigator and the research physician.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Changes in aerobic capacity and exercise tolerance over 3 month | — |
Secondary
| Measure | Time frame |
|---|---|
| Cardiac rehabilitation rates, frequency and burden of digital device use, changes in coronary artery disease risk (blood pressure levels, lipid profile, diabetes biomarkers, smoking habits), and changes in patient attitudes | — |
Countries
Japan
Contacts
Public ContactRyota Nishio
Juntendo University School of Medicine Department of Cardiovascular Biology and Medicine
Outcome results
None listed